Sharanya Shettigar. A Multicenter, Randomized, Double -Blind , Placebo-controlled Phase 3 Study to evaluate the efficacy and safety of Baricitinib in Adult Patients with Moderate to Severe a topic Dermatitis.
Cita Chicago (17th ed.)Sharanya Shettigar. A Multicenter, Randomized, Double -Blind , Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe a Topic Dermatitis.
Cita MLA (9th ed.)Sharanya Shettigar. A Multicenter, Randomized, Double -Blind , Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe a Topic Dermatitis.
Atenció: Aquestes cites poden no estar 100% correctes.